1. |
Clinical and Pharmacodynamic Studies of Omeprazole |
|
InPharma,
Volume &NA;,
Issue 553,
1986,
Page 2-3
&NA;,
Preview
|
PDF (1327KB)
|
|
ISSN:0156-2703
出版商:ADIS
年代:1986
数据来源: ADIS
|
2. |
Parkinsonian Symptoms Continue to be Difficult to Treat |
|
InPharma,
Volume &NA;,
Issue 553,
1986,
Page 3-4
&NA;,
Preview
|
PDF (1328KB)
|
|
ISSN:0156-2703
出版商:ADIS
年代:1986
数据来源: ADIS
|
3. |
Psychotherapeutic Prescribing In and Out of Hospital |
|
InPharma,
Volume &NA;,
Issue 553,
1986,
Page 4-5
&NA;,
Preview
|
PDF (1215KB)
|
|
ISSN:0156-2703
出版商:ADIS
年代:1986
数据来源: ADIS
|
4. |
Felodipine: causes arteriolar vasodilation without adversely affecting myocardial metabolism in patients with severe coronary disease |
|
InPharma,
Volume &NA;,
Issue 553,
1986,
Page 5-6
&NA;,
Preview
|
PDF (1303KB)
|
|
ISSN:0156-2703
出版商:ADIS
年代:1986
数据来源: ADIS
|
5. |
Darodipine: appears more effective than nifedipine in preventing exercise-induced asthma |
|
InPharma,
Volume &NA;,
Issue 553,
1986,
Page 6-6
&NA;,
Preview
|
PDF (703KB)
|
|
ISSN:0156-2703
出版商:ADIS
年代:1986
数据来源: ADIS
|
6. |
Oral Astemizole or Topical Sodium Cromoglycate for Seasonal Rhinitis? |
|
InPharma,
Volume &NA;,
Issue 553,
1986,
Page 7-8
&NA;,
Preview
|
PDF (1241KB)
|
|
ISSN:0156-2703
出版商:ADIS
年代:1986
数据来源: ADIS
|
7. |
Treating Ventricular and Supraventricular Arrhythmias with &bgr;-Blockers |
|
InPharma,
Volume &NA;,
Issue 553,
1986,
Page 8-9
&NA;,
Preview
|
PDF (1194KB)
|
|
ISSN:0156-2703
出版商:ADIS
年代:1986
数据来源: ADIS
|
8. |
Somatostatin and H2-Antagonists in Upper GI Bleeding |
|
InPharma,
Volume &NA;,
Issue 553,
1986,
Page 9-9
&NA;,
Preview
|
PDF (562KB)
|
|
ISSN:0156-2703
出版商:ADIS
年代:1986
数据来源: ADIS
|
9. |
Chemoprophylaxis Counteracts Postoperative Infections |
|
InPharma,
Volume &NA;,
Issue 553,
1986,
Page 10-11
&NA;,
Preview
|
PDF (1298KB)
|
|
ISSN:0156-2703
出版商:ADIS
年代:1986
数据来源: ADIS
|
10. |
Improving the Outlook in Severe Inflammatory Eye Disease |
|
InPharma,
Volume &NA;,
Issue 553,
1986,
Page 12-12
&NA;,
Preview
|
PDF (690KB)
|
|
ISSN:0156-2703
出版商:ADIS
年代:1986
数据来源: ADIS
|